3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Endocrine
1
CNS
1
Breast
1
Conditions
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Cyclophosphamide
137
Rituximab
112
Etoposide
77
Vincristine
74
Doxorubicin
61
Cytarabine
61
Dexamethasone
58
Prednisone
54
fludarabine
52
Methotrexate
46
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
42
Lenalidomide
36
Gemcitabine
35
Radiotherapy
29
Melphalan
27
pegaspargase
22
Prednisolone
22
Ifosfamide
22
Busulfan
20
fludarabine phosphate
19
Cisplatin
19
Bendamustine Hydrochloride
19
Asparaginase
18
Peripheral Blood Stem Cell Transplantation
17
Carmustine
16
ibrutinib
15
Mercaptopurine
15
Filgrastim
15
Decitabine
15
Oxaliplatin
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Diffusion Tensor Imaging
×
Lymphoid
×
Clear all
NCT03121456
2023-11-13
LYMPHODTECT
Centre Antoine Lacassagne
Phase NA
Unknown
74 enrolled